Citadel Advisors »

Benitec Biopharma shares owned by Citadel Advisors

Quarter-by-quarter ownership of Benitec Biopharma (BNTC) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Benitec Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Benitec Biopharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Benitec Biopharma by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $131k 14k 9.19
2023-09-30 $210k 70k 3.02

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Booking Holdings Call Option (BKNG)
Spdr Gold Tr Gold Shs Call Option (GLD)

View all positions for Citadel Advisors

Top funds holding Benitec Biopharma

Suvretta Capital Management
Henderson Group
Nantahala Capital Management
Franklin Resources
AWM Investment Company
Schonfeld Strategic Advisors
Vanguard Group
Simplify Asset Management
Geode Capital Management
BlackRock
BlackRock
Northern Trust
Citadel Advisors
GAMMA Investing
Morgan Stanley

View all funds holding Benitec Biopharma